与礼来、诺和诺德合作直供GLP-1减重药,Mangoceuticals股价飙升

智通财经
Nov 13, 2025

美国远程医疗平台 周四开盘股价飙升约19%,此前公司宣布与制药巨头 和 达成合作协议,将为用户直接提供两大药企的明星GLP-1减重药物。总部位于美国德州达拉斯的Mangoceuticals表示,公司已推出MangoRx Direct和PeachesRx Direct平台,面向自费用户销售礼来的 Zepbound(替尔泊肽)以及诺和诺德的Wegovy(司美格鲁肽)。编辑/KOKO

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10